The oversubscribed seed funding will be used to improve the storage and transportation of life-saving medicines, the company said.| Silicon Republic
Each week we highlight five things affecting the life sciences industry. Here’s the latest. ... READ MORE >| The Real Economy Blog
Heart devices lead medtech’s summer financing surge. This and more in this week’s life sciences update.| The Real Economy Blog
In this episode of AbbottTalks, Hosts Tom Salemi and Kayleen Brown sit down with Ethan Korngold, MD, Divisional Vice President, Medical Affairs and Chief Medical Officer of Abbott’s Vascular business, to discuss how artificial intelligence is reshaping decision-making in the […] The post Why Abbott’s vascular team sees AI as the GPS for the cath lab appeared first on DeviceTalks.| DeviceTalks
Each week we highlight five things affecting the life sciences industry. Here’s the latest.| The Real Economy Blog
Solventum's Rachel Ellingson shares a rare perspective on leading MedTech companies through major transitions, and outlines what’s ahead.| DeviceTalks
Innovation is at the heart of MedTech product development. As medical knowledge progresses and technology advances.| eLeaP®
Mabtech, a biotech company specializing in immunoassays for research and clinical diagnostics, sought to enhance the efficiency, user-friendliness, and accuracy of their key products like the FluoroSpot, ELISpot, and FociSpot readers. These improvements were crucial to strengthen their tools used in vaccine development and disease characterization amidst the global fight against diseases caused by viruses, bacteria, and parasites.| Qamcom